semaglutide training for nurse practitioners and Tirzepatide: Prescribing and Practice Growth Blog – Medical Weight Loss

Publicly available data from the ESSENCE trial do not allow an assessment of blood tests and other NITs that predict response to treatment (and this is generally an unmet need in clinical trials of MASH pharmacotherapy)

Tighter oversight of manufacturers pricing policies and the competitive environment Its unseemly (polite word choice) that the CEO of Lilly, Dave Ricks, is able to rake in total compensation of $114 million in 2024 while at the same time acknowledging that the price his company charges for Zepbound is too high. Unseemly, because his payday was fueled by Lilly making more than $10 billion in profit from GLP-1s in 2024 alone

Bottom Line Carbohydrates are important to incorporate into our diet, especially to ensure we are eating enough fiber

Comments on My Body First and foremost, I told the people closest to me (friends, family, coworkers) that I had started this medication for my health